SMS Highlights Innovative Pharma Solutions at Pharma Connect Congress 2024

On November 26, 2024, SMS takes center stage with an insightful presentation on “DAVAMED C1: A Cost-Effective, High-Performance Direct Compression Tablet Excipient.” Delivered by Dr. Siwarutt Boonyarattanakalin, Assistant Innovation Director, and Dr. Waesarat Soontornchaiboon, Product Innovation Manager, at Pharma Connect Congress 2024, a premier two-day event redefining the future of the pharmaceutical industry, held at the India Expo Centre, Delhi NCR, India.

India, known as the "pharmacy of the world," is the largest global provider of generic drugs and ranks third in pharmaceutical production volume. The congress explores strategies to strengthen pharma manufacturing while emphasizing innovation and sustainability across its sessions for future-ready pharma manufacturing.

The event focuses on the Pharma Manufacturing Conclave, which brings together decision-makers from manufacturers, academics, industry associations, contract manufacturing organizations, and other key stakeholders to brainstorm on navigating the challenges and discuss the road ahead. We have presented DAVAMED C1 as a innovative solution offering:

• Superior functionality and cost efficiency.
• Excellent flowability.
• High binding capacity.
• Disintegration capabilities.
• Adherence to global standards.

SMS’s participation highlights its commitment to driving innovation and supporting India’s growing influence in the global pharmaceutical sector. The opportunity to contribute to discussions on the future of pharma manufacturing aligns with our mission to deliver innovative, high-quality solutions. SMS is committed to fostering sustainable advancements and delivering solutions that address the evolving needs of the industry.